We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
175 result(s) found, displaying 161 to 170
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARANESP darbepoetin alfa (rch) 30 microgram/0.3mL injection syringe within a pen injector.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Denosumab
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARANESP darbepoetin alfa (rch) 500 microgram/1.0mL solution for injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARANESP darbepoetin alfa (rch) 150 microgram/0.3mL injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARANESP darbepoetin alfa (rch) 100 microgram/0.5mL injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARANESP darbepoetin alfa (rch) 300 microgram/0.6mL injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARANESP darbepoetin alfa (rch) 200 microgram/0.4mL injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARANESP darbepoetin alfa (rch) 15 microgram/0.38mL injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARANESP darbepoetin alfa (rch) 40 microgram/0.4mL injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARANESP darbepoetin alfa (rch) 20 microgram/0.5mL injection syringe.